vancomycin has been researched along with closantel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, JF; Demers, JP; Foleno, BD; Fraga-Spano, SA; Goldschmidt, RM; Hlasta, DJ; Johnson, SG; Kanojia, RM; Loeloff, MJ; Macielag, MJ; Russell, RK; Sui, Z; Webb, GC; Weidner-Wells, MA; Werblood, H | 1 |
| Abdeen, S; Ambrose, AJ; Chapman, E; Hoang, QQ; Johnson, SM; Kunkle, T; Park, Y; Ray, AM; Salim, N; Stevens, M; Victorino, J | 1 |
| AbdelKhalek, A; Abutaleb, NS; Mohammad, H; Seleem, MN | 1 |
3 other study(ies) available for vancomycin and closantel
| Article | Year |
|---|---|
Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterococcus faecium; Enzyme Inhibitors; Gram-Positive Bacteria; Luciferases; Methicillin Resistance; Microbial Sensitivity Tests; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Salicylanilides; Spores, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Transcription Factors; Vancomycin | 1998 |
Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus.
Topics: Amides; Anti-Bacterial Agents; Biofilms; Chaperonin 10; Chaperonin 60; HEK293 Cells; Humans; Staphylococcus aureus | 2018 |
Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Depsipeptides; Drug Repositioning; Feces; Humans; Intestines; Linezolid; Mice; Microbial Sensitivity Tests; Niclosamide; Oxyclozanide; Rafoxanide; Salicylanilides; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |